[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
From the Food and Drug Administration
December 6, 2000

Drug Product Problem Reports

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;284(21):2711. doi:10.1001/jama.284.21.2711-JFD00010-4-1

The US Pharmacopeia (USP) has ceased operating its Drug Product Problem Reporting Program, which enabled pharmacists and other health care professionals to report drug quality problems "so that its efforts an resources may be concentrated on medication error reporting and prevention." The FDA wishes to encourage those who used the USP program to report product quality problems as well as adverse medical events to MEDWATCH by phone ([800] FDA-1088), fax ([800] FDA-0178), mail (MEDWATCH, FDA, HF-2, 5600 Fishers Ln, Rockville, MD 20857), or online (http://www.accessdata.fda.gov/scripts/medwatch).

First Page Preview View Large
First page PDF preview
First page PDF preview
×